The supportive criteria are: brain MRI finding not meeting criteria for MS at disease onset, spinal cord MRI with contiguous T2-weighted signal abnormality extending over three or more vertebral segments indicating a relatively large lesion in the spinal cord, and a positive aquaporin-4 antibody test. The gene discussed is AQP4; the disease is myeloid sarcoma.